Subscribe to Newsletter
Fields & Applications Mass Spectrometry, Proteomics

Structural Proteomics Takes Aim at Disease

Unlike the genome, which is relatively static, the proteome is dynamic, constantly changing in response to intracellular and extracellular environmental signals. Modern mass spectrometric techniques, electro-spray ionization and matrix assisted laser desorption ionization, are capable enough to take the “molecular elephants” of the proteome into gas phase, thereby studying them individually and collectively in hetero-molecular assemblies (1, 2). 

This has huge implications for medicine. In patients, a variety of factors have a bearing on protein expression and post-translation modification, including the disease itself, pharmacological interventions, genetic factors and environmental variables. High throughput analysis of the proteome in a limited clinical sample is already feasible and ongoing improvements to increase resolution, sensitivity, mass accuracy and analysis speed of mass spectrometers along with the advent of higher order dimensions in separation will permit proteomic analysis of virtually any challenging clinical sample in a single step in the near future.

So what is the next quantum step?  Proteomics need not be restricted to a study of primary structure. It can be extended to assess the thermodynamic stability of the three-dimensional structure of proteins, finally to arrive at an understanding of molecular mechanisms through structure-function correlation. 

The discovery of protein structures has – since alterations in the chemical structure of hemoglobin in sickle cell anemia was achieved in the 1950s (3) – made it possible to assign disease to the functional disorder of a few atoms. However, structural analysis has been confronted with three issues. First, using any spectroscopic tool has required pure protein in large quantities, which is difficult to achieve with clinical samples. Second, due to complex milieu of molecules in the cell, in vitro stability parameters might not be exactly the same as those that occur in vivo.

Proteomics can be extended to assess the thermodynamic stability of the three-dimensional structure of proteins.

And third, most spectroscopic methods that monitor molecular properties are not molecule-specific; rather, they are functional group-specific making it impossible to have structure-function analysis at the residue levels of a protein in vivo.

In patients, a variety of factors have a bearing on protein expression and post-translation modification

We believe that the solution to these problems lies with hydrogen deuterium exchange-based mass spectrometry (HDX-MS). By exploiting the permeability of heavy water (D2O) through cell membranes, HDX-MS has been used to measure the thermodynamic stability of intact protein structure in vivo (4). HDX-MS has also been applied in vitro to establish structure-function correlations at the residue level of proteins in non-covalently bonded complexes by studying the kinetics of isotope-exchange patterns (5).

Ion mobility spectrometry (IMS) adds a further dimension to structural proteomics research by separating molecules on the basis of shape. The combination of HDX-MS and IMS can be used to explore the underlying mechanisms of protein folding and  protein-ligand interactions in normal and disease situations. In our view, an investigation of protein function through structure-function correlation in vivo using isotope exchange-based mass spectrometry would be an important scientific breakthrough, one that connects us back to the origins of molecular medicine with the discovery of the molecular basis of sickle cell anemia in 1949 (6).

Receive content, products, events as well as relevant industry updates from The Analytical Scientist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. JB Fenn et al.,“Electrospray ionization for mass spectrometry of large bio molecules”,Science, 246, 64– 71 (1989).
  2. K. Tanaka et al.,“Protein and polymer analyses upto m/z 100 000 by Laser Ionisation Time-of-flight Mass Spectrometry”, Rapid Comm Mass Spec, 2, 151-153 (1988).
  3. V.M. Ingram, “Gene mutations in human haemoglobin : The chemical difference between normal and sickle haemoglobin” Nature 180: 326 (1957).
  4. S. Ghaemmaghami and T. G. Oas,“Quantitative protein stability measurement in vivo”Nature Structural Biol. 8, 879-82 (2001).
  5. G. Mitra et al.,“Glutathionylation Induced Structural Changes in Oxy Human Hemoglobin Analyzed by Backbone Amide Hydrogen/Deuterium Exchange and MALDI-Mass Spectrometry,” Bioconjugate Chem., 23, 2344-53 (2012).
  6. L.Pauling et al.,“Sickle Cell Anemia, a Molecular Disease”, Science, 110, 543-548 (1949).
About the Authors
Amrita Mitra

Amrita Mitra, student of Amit Kumar Mandal at the St. John’s Research Institute in Bangalore, India, finds structural biology a fascinating field. “My work involves mass spec-based proteomics to explore the urine proteome to identify candidate biomarkers for prostate cancer.”


Amit Kumar Mandal

“I was more inclined to be a teacher than a scientist,” says Amit Kumar Mandal of the St. John’s Research Institute in Bangalore, India, “but a fascination with the correlation between molecular structure and function dragged me into research.” His was drawn to mass spectrometry because the kinetics of a chemical reaction can be visualized through it. “When I realized that structural biology can be solved using isotope exchange-based and ion mobility-based mass spectrometry” he says, “my excitement touched the roof.”

Related Application Notes
FUSION PTR-TOF ABOARD NASA DC-8 FOR ASIA-AQ CAMPAIGN

| Contributed by IONICON

An End-to-End Targeted Metabolomics Workflow

| Contributed by Agilent Technologies

Charge heterogeneity characterisation of an IgG4-based mAb using AEX coupled to MS

| Contributed by YMC

Related Product Profiles
Higher Peaks – Clearly.

| Contributed by Shimadzu Europa

Compact with countless benefits

| Contributed by Shimadzu Europa

The fine Art of Method Development

| Contributed by Shimadzu Europa

Register to The Analytical Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Analytical Scientist magazine

Register